National Institutes of Health, National Institute of Allergy and Infectious Diseases: FOR RELEASE Wednesday, Feb. 11, 1998
John Bowersox (301) 402-1663 jbowersox@nih.gov
A two-month course of therapy to prevent active tuberculosis (TB) is an effective alternative to the year-long regimen currently prescribed for persons co-infected with HIV and TB bacteria, a five- year international study has found. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIA
National Institutes of Health, National Institute of Allergy and Infectious Diseases; FOR RELEASE Monday, Feb. 2, 1998
Greg Folkers (301) 496-2263 gfolkers@nih.gov
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID) have helped answer an important question in the treatment of HIV-infected individuals: why, in patients receiving aggressive antiretroviral therapy who have no easily detectable HIV in their blood, does the virus rapidly rebound to high le
National Institutes of Health; National Institute of Allergy and Infectious Diseases; Wednesday, January 14, 1998
Laurie K. Doepel (301) 402-1663 ldoepel@nih.gov
Investigators supported by the National Institute of Allergy and Infectious Diseases (NIAID) have begun enrolling volunteers in three new clinical trials of novel HIV vaccine approaches. The trials are testing a novel route of immunization, an innovative vaccine strategy and a new adjuvant, or vaccine booster. Voluntee
National Institutes of Health National Institute of Allergy and Infectious Diseases: EMBARGOED FOR RELEASE Thursday, Jan. 1, 1998 4:00 p.m. Eastern Time
John Bowersox (301) 402-1663 jbowersox@nih.gov
An unusual enzyme never before seen in viruses appears to shield an AIDS-related skin disease virus from the ravages of ultraviolet (UV) radiation and the immune system, according to a study by researchers from the National Institute of Allergy and Infectious Diseases (NIAID). This is an interesting finding that uncove
This information is designed to support, not replace, the relationship that exists between you and your doctor.